 BERKELEY, Calif. and MAINZ, Germany, May 17, 2022 GLOBE NEWSWIRE -- Mainz Biomed N.V. NASDAQ:MYNZ Mainz Biomed or the Company, a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that members of its executive team will be participating in two notable investor conferences in May, 2022, the H.C. Wainwright Global Investment Conference and the Equity Forum German Spring Conference. 